Sequence information
Variant position: 803 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 928 The length of the canonical sequence.
Location on the sequence:
PHIPRSPYKFPSSPLRIPGG
N IYISPLKSPYKISEGLPTPT
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PHIPRSPYKFPSSPLRIPGG-N IYISPLKSPYKISEGLPTPT
Mouse PHIPRSPYKFSSSPLRIPGG-N IYISPLKSPYKISEGLPTP
Rat PHIPRSPYKFSSSPLRIPGG-N IYISPLKSPYKISEGLPTP
Chicken PHIPRSPYQFSNSPRRVPAGNN IYISPLKSPYKFSDGFHSP
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 928
Retinoblastoma-associated protein
Region
763 – 928
Interaction with LIMD1
Region
771 – 928
Domain C; mediates interaction with E4F1
Modified residue
788 – 788
Phosphoserine
Modified residue
795 – 795
Phosphoserine
Modified residue
807 – 807
Phosphoserine; by CDK1 and CDK3
Modified residue
810 – 810
N6-methyllysine; by SMYD2
Modified residue
811 – 811
Phosphoserine; by CDK1 and CDK3
Modified residue
821 – 821
Phosphothreonine; by CDK6
Modified residue
823 – 823
Phosphothreonine
Mutagenesis
821 – 821
T -> A. Abolishes interaction with Pocket domain; when associated with A-826.
Literature citations
Germline mutations in the RB1 gene in patients with hereditary retinoblastoma.
Liu Z.; Song Y.; Bia B.; Cowell J.K.;
Genes Chromosomes Cancer 14:277-284(1995)
Cited for: VARIANTS RB GLN-72; TYR-549 AND LYS-803;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.